E. Montechiarello

发表

Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi

M. Federico, L. Baldini, F. Merli, 2014, Leukemia & lymphoma.

Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study

E. Iannitto, M. Federico, F. Merli, 2015, Leukemia & lymphoma.

Lymphoma R-COMP as a first-line treatment for Splenic Marginal Zone Lymphoma . A Fondazione Italiana Linfomi phase II study

E. Iannitto, M. Federico, F. Merli, 2015 .

Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi

S. Pileri, R. Fanin, S. Ferrero, 2017, Haematologica.